These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6165189)

  • 41. Influence of the diet on the plasma kinetics of 8-methoxypsoralen.
    Bonnot D; Beani JC; Beriel H; Boitard M; Amblard P; Reymond JL
    Dermatologica; 1985; 171(6):442-5. PubMed ID: 4092799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronopharmacokinetics of 5-methoxypsoralen.
    Treffel P; Renaud A; Humbert P; Makki S; Faivre B; Agache PG
    Acta Derm Venereol; 1990; 70(6):515-7. PubMed ID: 1981428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variations in skin photosensitization during repeated oral 8-methoxypsoralen medication.
    Jansén CT; Wilén G; Paul R
    Arch Dermatol Res; 1983; 275(5):315-7. PubMed ID: 6660903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum levels of 8-methoxypsoralen: difference between two oral methods of administration.
    Stolk L; Kammeyer A; Cormane RH; Van Zwieten PA
    Br J Dermatol; 1980 Oct; 103(4):417-20. PubMed ID: 7437307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro dissolution rates of six 8-methoxypsoralen formulations.
    Stolk LM; Pasman A; Cormane RH; Van Zweiten PA
    Br J Dermatol; 1987 Jun; 116(6):813-21. PubMed ID: 3620342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversible binding of 5- and 8-methoxypsoralen to human serum proteins (albumin) and to epidermis in vitro.
    Artuc M; Stuettgen G; Schalla W; Schaefer H; Gazith J
    Br J Dermatol; 1979 Dec; 101(6):669-77. PubMed ID: 534612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 8-Methoxypsoralen levels in blood of vitiligo patients and in skin, ophthalmic fluids, and ocular tissues of the guinea pig.
    Chakrabarti SG; Halder RM; Johnson BA; Minus HR; Pradhan TK; Kenney JA
    J Invest Dermatol; 1986 Aug; 87(2):276-9. PubMed ID: 3734475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comments on the paper by V. Nitsche et al.: 8-Methoxypsoralen (8-MOP) in neuer galenischer Zubereitung und seine Beziehung zum 8-MOP-Serumspiegel. 8-Methoxypsoralen (8-MOP)--a new galenic form and its relation to 8-MOP serum levels.
    Siddiqui AH
    Arch Dermatol Res; 1982; 272(1-2):181. PubMed ID: 7165319
    [No Abstract]   [Full Text] [Related]  

  • 49. A method for the determination of PUVA-induced in vivo irreversible binding of 8-methoxypsoralen (8-MOP) to epidermal lipids, proteins and DNA/RNA.
    Beijersbergen van Henegouwen GM; Wijn ET; Schoonderwoerd SA; Dall'Acqua F
    J Photochem Photobiol B; 1989 Aug; 3(4):631-5. PubMed ID: 2477521
    [No Abstract]   [Full Text] [Related]  

  • 50. Problems with commercial formulations of 8-methoxypsoralen.
    Monbaliu JG; Bogaert MG; De Bersaques J; Hindryckx P
    Dermatologica; 1981; 163(6):468-73. PubMed ID: 7333402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum and urine concentrations of 5-methoxypsoralen after oral administration.
    Stolk LM; Westerhof W; Cormane RH; van Zwieten PA
    Br J Dermatol; 1981 Oct; 105(4):415-9. PubMed ID: 7295552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 8-methoxypsoralen and the eye.
    Marqversen J; Axelsen I; Nielsen E; Zachariae H
    Arch Dermatol Res; 1981; 270(4):387-90. PubMed ID: 7283466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study of the bioavailability of different formulations of 8-methoxypsoralen in the dog.
    Monbaliu JG; Belpaire FM; Bogaert MG
    Biopharm Drug Dispos; 1988; 9(1):1-8. PubMed ID: 3342281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of 8-methoxypsoralen in plasma by electron capture gas chromatography.
    Ehrsson H; Eksborg S; Wallin I; Kållberg N; Swanbeck G
    J Chromatogr; 1977 Oct; 140(2):157-64. PubMed ID: 914909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. About 8-methoxypsoralen: difference in the efficiency of two delivery forms.
    van Hofwegen PM; Winkelman A
    Dermatologica; 1979; 158(4):307. PubMed ID: 428617
    [No Abstract]   [Full Text] [Related]  

  • 56. Binding of 5-methoxypsoralen to human serum low density lipoproteins.
    Melo Tde S; Morlière P; Goldstein S; Santus R; Dubertret L; Lagrange D
    Biochem Biophys Res Commun; 1984 Apr; 120(2):670-6. PubMed ID: 6732778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 8-Methoxypsoralen-gas chromatographic determination and serum kinetics.
    Gazith J; Schalla W; Schaefer H
    Arch Dermatol Res; 1978 Nov; 263(2):215-22. PubMed ID: 736606
    [No Abstract]   [Full Text] [Related]  

  • 58. Rapid and sensitive analysis of 8-methoxypsoralen in plasma.
    Gasparro FP; Battista J; Song J; Edelson RL
    J Invest Dermatol; 1988 Feb; 90(2):234-6. PubMed ID: 3339265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variations in plasma levels with 12 different forms of methoxsalen.
    Roelandts R; Van Boven M; De Greef H; Kinget R; Adriaens P; Daenens P
    Arch Dermatol; 1984 Oct; 120(10):1281-2. PubMed ID: 6486841
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of hypochromiant chronic solar dermatosis with 8-methoxypsoralen ammoidin. Preliminary report of 67 treated cases].
    Ramírez O; Reyes G
    Actas Dermosifiliogr; 1977; 68(5-6):273-8. PubMed ID: 920325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.